Sign in
4

Changes in Ownership

MAXCYTE, INC. Filed Acc 0001209191-23-024116

EVP, Global Sales & Marketing sold 14,134 shares at $5.00 ($70,670)

  • EVP, Global Sales & Marketing acquired 14,134 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Ross Thomas M. EVP, Global Sales & Marketing 2023-04-10 Option exercise 10b5-1 +100 $2.14 $214 100 D
Ross Thomas M. EVP, Global Sales & Marketing 2023-04-10 Sale 10b5-1 −100 $5.00 $500 0 D
Ross Thomas M. EVP, Global Sales & Marketing 2023-04-11 Option exercise 10b5-1 +8,451 $2.14 $18,102 8,451 D
Ross Thomas M. EVP, Global Sales & Marketing 2023-04-11 Sale 10b5-1 −8,451 $5.00 $42,255 0 D
Ross Thomas M. EVP, Global Sales & Marketing 2023-04-12 Option exercise 10b5-1 +5,583 $2.14 $11,959 5,583 D
Ross Thomas M. EVP, Global Sales & Marketing 2023-04-12 Sale 10b5-1 −5,583 $5.00 $27,915 0 D
Derivatives
Ross Thomas M. EVP, Global Sales & Marketing 2023-04-10 Option exercise · Employee Stock Option (right to buy) 10b5-1 −100 27,902 D
Ross Thomas M. EVP, Global Sales & Marketing 2023-04-11 Option exercise · Employee Stock Option (right to buy) 10b5-1 −8,451 19,451 D
Ross Thomas M. EVP, Global Sales & Marketing 2023-04-12 Option exercise · Employee Stock Option (right to buy) 10b5-1 −5,583 13,868 D
Open-market sales · 14,134 sh · avg $5.00 · $70,670
Loading xslF345X04/doc4.xml…